Navigation Links
CDC traumatic brain injury study to test treatments, examine outcomes
Date:9/6/2012

Keith Yeates, PhD, director of the Center for Biobehavioral Health in The Research Institute at Nationwide Children's Hospital, has been designated lead neuropsychologist for a five-year, multisite study of traumatic brain injury (TBI) among United States children, funded by the Centers for Disease Control and Prevention. The grant is for approximately $2.75 million.

"We know surprisingly little about the effects of treatment on the outcomes of traumatic brain injury in children and adolescents," said Dr. Yeates. "The results of this study should help us provide parents of children with TBI with better evidence-based recommendations for their children's care."

The study will include children 8 to 18 years and is designed to examine the effect of treatment during the acute, short-term and longer-term phases of care on the functional, psychosocial and disability outcomes after traumatic brain injury.

The study consortium involves investigators at Harborview Medical Center and Seattle Children's Hospital, Texas Children's Hospital, Children's Hospital of Philadelphia, and Nationwide Children's. In addition to his role as the study's lead neuropsychologist, Dr. Yeates, also a faculty member at The Ohio State University College of Medicine, will also serve as Nationwide Children's principal investigator on the grant.


'/>"/>
Contact: Erin Pope
Erin.Pope@NationwideChildrens.org
614-355-0495
Nationwide Children's Hospital
Source:Eurekalert

Page: 1

Related medicine news :

1. Repeated exposure to traumatic images may be harmful to health
2. Traumatic childhood may increase the risk of drug addiction
3. Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury
4. War is not necessarily the cause of post-traumatic stress disorder
5. Traumatic brain injury the focus of American Headache Society scientific conference
6. Predicting post-traumatic stress disorder before it happens
7. Diabetes drug could be a promising therapy for traumatic brain injury
8. Preventing post-traumatic stress
9. Reducing post-traumatic stress after ICU
10. Mild traumatic brain injury may contribute to brain network dysfunction
11. New standards for treating traumatic shoulder injuries to improve patient care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2017)... ... January 15, 2017 , ... ... physicians in eight Bay Area counties for 2017. Almost 1,000 nominations were submitted ... managing the award process. Results were announced the magazine’s January 2017 issue ...
(Date:1/14/2017)... ... 14, 2017 , ... Healthy living brand Moody Zook recently ... products. With more and more people opting to go organic in their lifestyle, ... cater to specific needs. , Moody Zook focused particularly on their newly launched ...
(Date:1/13/2017)... ... January 13, 2017 , ... ... sugar levels. Counting carbohydrates is as easy as checking the nutrition label on ... affects blood sugar levels. Despite being sugar-free, proteins can influence — either positively ...
(Date:1/13/2017)... ... January 13, 2017 , ... With the increasing public preference ... providing additional organic alternatives for customers who have grown more conscious about maintaining ... of all-natural activated charcoal products, Moody Zook Chief Executive Officer Nate Ginsburg explained ...
(Date:1/13/2017)... ... ... "We wanted to create a design for orthodontic appliances that would make ... Beach, Va. , They created a prototype for the patent-pending BRACE FACERS to add ... be customized to suit personal tastes. They can be used to create custom designs ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... January 13, 2017 Constant research ongoing ... will collectively contribute to the demand for western blotting technique. ... value of US$ 551.0 Mn by 2016 end. Developing economies ... most lucrative markets for western blotting, whereas North ... ...
(Date:1/13/2017)... NEW YORK , January 13, 2017 ... Biotech equities to see how they have fared at ... CLVS ), Galena Biopharma Inc. (NASDAQ: GALE ... ). These companies harness cellular and biomolecular processes to ... diseases, reduce our environmental footprint, feed the hungry, use ...
(Date:1/13/2017)... 2017   JDRF , the leading global ... pleased to announce that after more than a ... & Medicaid Services (CMS) has recognized continuous glucose ... use in making diabetes treatment decisions as durable ... eligible for coverage under Medicare. JDRF has been ...
Breaking Medicine Technology: